UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$191M |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$157M |
| 3 |
Pfizer
PFE
|
+$139M |
| 4 |
3M
MMM
|
+$131M |
| 5 |
Meta Platforms (Facebook)
META
|
+$106M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALTR
Altera Corp
ALTR
|
+$288M |
| 2 |
Intercontinental Exchange
ICE
|
+$247M |
| 3 |
RKT
ROCK-TENN COMPANY CL-A
RKT
|
+$142M |
| 4 |
Yelp
YELP
|
+$140M |
| 5 |
Salesforce
CRM
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.28% |
| 2 | Financials | 14.69% |
| 3 | Technology | 14.25% |
| 4 | Consumer Discretionary | 9.55% |
| 5 | Industrials | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ACET
2201
DELISTED
Aceto Corp
ACET
| $355K | ﹤0.01% |
14,400
| – | – |
|
|
MWW
2202
DELISTED
Monster Worldwide Inc
MWW
| $355K | ﹤0.01% |
54,295
+1,500
| +3% | +$9.32K |
|
|
EVRI
2203
DELISTED
Everi Holdings
EVRI
| $354K | ﹤0.01% |
45,768
+8,800
| +24% | +$68.8K |
|
2204
Geron
GERN
$1B
| $354K | ﹤0.01% |
82,900
+2,400
| +3% | +$9.51K |
|
2205
Helios Technologies
HLIO
$2.72B
| $354K | ﹤0.01% |
9,300
+1,400
| +18% | +$54.3K |
|
2206
Resources Connection
RGP
$154M
| $354K | ﹤0.01% |
21,998
+600
| +3% | +$9.81K |
|
2207
LendingTree
TREE
$473M
| $354K | ﹤0.01% |
4,500
+200
| +5% | +$12.3K |
|
|
HTO
2208
H2O America
HTO
$2.57B
| $353K | ﹤0.01% |
11,499
+300
| +3% | +$9.05K |
|
|
ZAYO
2209
DELISTED
Zayo Group Holdings, Inc.
ZAYO
| $353K | ﹤0.01% |
+13,742
| New | +$373K |
|
|
RT
2210
DELISTED
Ruby Tuesday Georgia
RT
| $352K | ﹤0.01% |
56,197
+1,400
| +3% | +$9.41K |
|
|
EPIQ
2211
DELISTED
EPIQ SYSTEMS INC
EPIQ
| $351K | ﹤0.01% |
20,798
+4,100
| +25% | +$70.9K |
|
2212
Travere Therapeutics
TVTX
$5.8B
| $348K | ﹤0.01% |
+10,500
| New | +$288K |
|
|
RSTI
2213
DELISTED
Rofin-Sinar Technologies Inc
RSTI
| $348K | ﹤0.01% |
12,600
+2,400
| +24% | +$64.8K |
|
2214
Myers Industries
MYE
$1.35B
| $346K | ﹤0.01% |
18,199
+600
| +3% | +$10.6K |
|
|
UAM
2215
DELISTED
Universal American Corp
UAM
| $346K | ﹤0.01% |
34,197
+7,400
| +28% | +$77.1K |
|
2216
Ethan Allen Interiors
ETD
$624M
| $345K | ﹤0.01% |
13,099
+400
| +3% | +$10.3K |
|
|
WAC
2217
DELISTED
Walter Investment Mgt Corp
WAC
| $345K | ﹤0.01% |
15,099
+500
| +3% | +$9.53K |
|
2218
AMERISAFE
AMSF
$556M
| $344K | ﹤0.01% |
7,300
| – | – |
|
2219
ArcBest
ARCB
$3.2B
| $343K | ﹤0.01% |
10,800
+300
| +3% | +$10.7K |
|
2220
American Vanguard Corp
AVD
$72.7M
| $343K | ﹤0.01% |
24,890
+800
| +3% | +$10.5K |
|
2221
Rush Enterprises Class A
RUSHA
$6.42B
| $343K | ﹤0.01% |
29,473
+5,625
| +24% | +$67.6K |
|
2222
UFP Industries
UFPI
$5.24B
| $343K | ﹤0.01% |
19,800
+600
| +3% | +$11K |
|
|
JE
2223
DELISTED
Just Energy Group Inc
JE
| $343K | ﹤0.01% |
1,995
+57
| +3% | +$9.87K |
|
|
CLD
2224
DELISTED
Cloud Peak Energy Inc
CLD
| $343K | ﹤0.01% |
73,583
+1,500
| +2% | +$8.68K |
|
2225
CVR Energy
CVI
$3.15B
| $342K | ﹤0.01% |
9,099
+1,600
| +21% | +$63.1K |
|
Similar funds
UBS AM's Q2 2015 Portfolio in Review
As of Q2 2015, UBS AM held 2,771 positions worth $104B, up 0.68% from $104B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM's Q2 2015 filing shows 148 new, 1,779 increased, 566 reduced and 77 closed positions. Its largest new stake was Viatris: 1,260,214 shares worth $85.5M. The largest sale was Altera Corp, an estimated $288M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 17% a quarter earlier, followed by Financials and Technology.
- UBS AM's largest Q2 2015 buy was Viatris: 1,260,214 shares worth $85.5M.
- UBS AM added most to Allergan plc in Q2 2015, an estimated $191M increase.
- UBS AM's biggest Q2 2015 reduction was Altera Corp, cutting an estimated $288M.
- UBS AM fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $78.3M.
- UBS AM's ten largest holdings make up 14% of its $104B portfolio in Q2 2015.
- UBS AM opened 148 new positions and closed 77 in Q2 2015.
- UBS AM's portfolio value rose 0.68% quarter-over-quarter to $104B.
Based on UBS AM's 13F filing for Q2 2015, filed 12 Aug 2015.